Zealand Pharma A/S (($DK:ZEAL)) has held its Q1 earnings call. Read on for the main highlights of the call. Zealand Pharma’s recent earnings call ...

Zealand Pharma AS (ZLDPF) reports robust financials and transformative partnerships, setting the stage for future growth in ...

No. 12 / 2025 Zealand Pharma announces closing of collaboration and license agreement with Roche Copenhagen, Denmark, May 9, ...

M&A and IPOs got off to a quick start in 2025 only to crash into a wall of policy challenges. Upfront payment for licensing ...

Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, ...

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs ...

Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

Hong Kong's Hang Seng Index added roughly 1.7% on news that China is evaluating the prospect of talks with the U.S. The ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

In theory, a lower-value dollar will boost exports from the US, but there is no guarantee that this will happen if reciprocal ...

As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...